FDA Inspection 1120578 — Audentes Therapeutics, Inc.
The FDA completed an inspection of Audentes Therapeutics, Inc. on February 19, 2020 in San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 19, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- San Francisco, CA (United States)
Additional Details
Sponsor, Contract Research Organization